Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.22% is 62% below its 5-year average of 0.58%, near the low end of its 5-year range (0.07%–0.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.23% below its 12-month average of 0.40%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.22%.
DEBT TO ASSETS RATIO
0.22%
DEBT TO ASSETS RATIO AVG TTM
0.40%
DEBT TO ASSETS RATIO AVG 3Y
0.40%
DEBT TO ASSETS RATIO AVG 5Y
0.58%
DEBT TO ASSETS RATIO AVG 10Y
0.39%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-44.23%
CURRENT VS 3Y AVG
-44.64%
CURRENT VS 5Y AVG
-61.61%
CURRENT VS 10Y AVG
-43.17%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+148.28%
vs the sector median at left
Oruka Therapeutics, Inc.
Market Cap
$4.84B
Debt to Assets Ratio
0.22%
TTM Avg
0.40%
3Y Avg
0.40%
5Y Avg
0.58%
Market Cap
$4.83B
Debt to Assets Ratio
0.73%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.78B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.73B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.70B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.64B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.06B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.07B
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | $4.84B | 0.22% | 0.40% | 0.40% | 0.58% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | 0.73% | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | 0.00% | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | 0.03% | N/A | N/A | N/A |
| Erasca, Inc. (ERAS)vs › | $4.96B | 0.10% | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 0.09% | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 0.38% | N/A | N/A | N/A |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 0.25% | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 0.29% | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 0.20% | N/A | N/A | N/A |
Debt/Assets
0.2%
Debt/Equity
0.00
Current Ratio
38.51
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.22% |
| 2026-03-31 | 0.36% |
| 2025-12-31 | 0.40% |
| 2025-09-30 | 0.38% |
| 2025-06-30 | 0.65% |
| 2025-03-31 | 0.25% |
| 2024-12-31 | 0.24% |
| 2024-09-30 | 0.24% |
| 2024-06-30 | 0.07% |
| 2024-03-31 | 0.13% |
| 2023-12-31 | 0.74% |
| 2023-09-30 | 0.77% |
| 2023-06-30 | 0.80% |
| 2023-03-31 | 0.85% |
| 2022-12-31 | 0.89% |
| 2022-09-30 | 0.91% |
| 2022-06-30 | 0.90% |
| 2022-03-31 | 0.90% |
| 2021-12-31 | 0.88% |
| 2021-09-30 | 0.84% |
| 2021-06-30 | 0.80% |
| 2021-03-31 | 0.65% |
| 2020-12-31 | 0.89% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.21% |
| 2020-03-31 | 0.67% |
| 2019-12-31 | 0.29% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
